Jonathan Demchick

Globus Medical Inc (NASDAQ: GMED), a medical device company that's among the major players in spine robotic surgery technologies, saw its stock gain more than 70 percent in 2017, and one analyst projects more upside in 2018.  The Analyst Morgan Stanley's Jonathan Demchick...

Morgan Stanley analysts David Lewis and Jonathan Demchick raised their price target on Intuitive Surgical, Inc. (NASDAQ: ISRG) from $840 to $950. The analysts maintain an Overweight rating. Lewis and Demchick highlighted Intuitive posted five straight quarters of company-adjusted procedure...

Morgan Stanley analysts David Lewis and Jonathan Demchick believe Hill-Rom Holdings, Inc. (NYSE: HRC)'s story has not been fully appreciated by the Street. The analysts placed this opinion against the backdrop of the company's recent creation of a more sustainable sales base, which boosts the...